Limited coverage drugs – rufinamide
Last updated on September 26, 2024
|
Generic name |
rufinamide | |
|---|---|---|
|
Strength |
100 mg, 200 mg, 400 mg | |
| Form | tablet | |
| Special Authority criteria | Approval period |
|---|---|
|
For the treatment of Lennox-Gastaut syndrome (LGS) when prescribed by a neurologist as adjunctive therapy in a patient who is currently taking at least two other anti‑epileptic drugs.
|
Indefinite |
Practitioner exemptions
- None
Special notes
- None